awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33413598-CD7FEBEA-3BFA-43E2-80E8-FCD3BAFBC2EB
Q33413598-CD7FEBEA-3BFA-43E2-80E8-FCD3BAFBC2EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33413598-CD7FEBEA-3BFA-43E2-80E8-FCD3BAFBC2EB
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
P2860
Q33413598-CD7FEBEA-3BFA-43E2-80E8-FCD3BAFBC2EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33413598-CD7FEBEA-3BFA-43E2-80E8-FCD3BAFBC2EB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4a7fcdd583ee0931e4a8346e943e4c02c53f30b
P2860
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.